Cerebrovascular Disease
Conditions
Interventions
intensive group:atrovastatin 80mg×14day
control group:atrovastatin 20mg×14day
Sponsors
Beijing Luhe Hospital, Capital Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: Acute ischemic stroke patients with new focal neuro-signs should be proved new infarction lesions exist by CT/MRI. Patients' disease time should be less than 24 hours or they have advancing stroke. Patients who agree to take the trial should sign the informed consents first.
Exclusion criteria
Exclusion criteria: Patients whose ages are less than 18 years or more than 80 years will not be included. Patients whose liver founction or creatine kinase is apparently abormal will not be included.Patients who have serious heart diseases, cancers, allergy to atorvastatin, difficulties of follow-up or life expectancy less than 1 year will not be included. Patients who refuse sign the informed consents will also be excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| NIHSS Score; | — |
Countries
China
Contacts
Public ContactTAN XIAOMU
Outcome results
None listed